So, here's a classic Wall Street story: a company reports earnings that are technically better than expected, but the market decides it doesn't like what comes next. That's what happened to Amdocs Limited (DOX) this week.

The software provider for telecom companies announced fourth-quarter results that, on the surface, looked solid. They earned $1.83 per share, a penny above the consensus estimate of $1.82. Revenue came in at $1.150 billion, also slightly beating the expected $1.146 billion. Not a blowout, but a beat is a beat.

Then came the guidance. For the current quarter, Amdocs sees adjusted earnings per share in the range of $1.73 to $1.79. The problem? The market was expecting $1.87. On the sales front, the company forecast $1.135 billion to $1.175 billion, which brackets the consensus estimate of $1.153 billion but suggests the midpoint might be a bit light.

Investors didn't stick around to parse the nuances. The stock dropped 7.5% to $77.64 on Wednesday. When you guide below expectations, even after a beat, the market tends to sell first and ask questions later.

In the company's official statement, President and CEO Shuky Sheffer struck an optimistic tone. "Fiscal 2025 was another important year as we delivered financial results consistent with our expectations while serving our global telecommunications customers with cutting-edge cloud, digital and AI-driven solutions designed to meet their strategic imperatives," Sheffer said. He highlighted that cloud-related revenue grew at a double-digit pace and now makes up over 30% of total sales, adding that the year "finished with very strong sales momentum."

The analyst reaction was a study in measured disappointment. Two major firms immediately tweaked their models.

• B of A Securities analyst Tal Liani maintained a Buy rating on the stock but lowered his price target from $100 to $97.
• Stifel analyst Shlomo Rosenbaum also kept a Buy rating but similarly cut his price target from $100 to $97.

It's the Wall Street equivalent of a gentle scolding. The analysts are still bullish on the long-term story—hence the maintained Buy ratings—but the weaker near-term guide means the stock's path to their previous targets got a bit longer. So, they shaved a few dollars off to reflect the new, slightly more cautious timeline.

The takeaway? Amdocs is executing on its cloud and digital transformation strategy, which is winning praise from management. But for now, the market is more focused on the fact that the next few months might not be as strong as everyone had hoped. It's a reminder that in earnings season, it's not just what you did last quarter that matters; it's what you say you're going to do next.